March 2015
Asset deal
Christophe Cancel has advised IDD Biotech in the assignment to Genmab NV of DR5 antibodies for the treatment of cancers.
www.idd-biotech.com
www.genmab.com
January 2015
Fund raising
Christophe Cancel has advised IDD Biotech (a company developing innovative monoclonal antibodies for therapeutic uses) in the frame of its latest fundraising, to which Substipharm has subscribed.
www.idd-biotech.com
http://substipharm.fr/fr
ADDRESS
38, avenue Hoche
75008 Paris – France
PHONE & FAX
T +33 (0)1 45 62 72 92
F +33 (0)1 42 89 58 96
Cancel Avocats
CANCEL AVOCATS
38 AVENUE HOCHE
75008 PARIS
MEMBER OF IACF LEGAL NOTICE COPYRIGHT: CANCEL AVOCATS ALL RIGHT RESERVED CONCEPTION: VALORUS